PAFR/Stat3 axis maintains the symbiotic ecosystem between tumor and stroma to facilitate tumor malignancy.
10.1016/j.apsb.2022.08.014
- Author:
Di ZHAO
1
;
Jing ZHANG
1
;
Lingyuan ZHANG
1
;
Qingnan WU
1
;
Yan WANG
1
;
Weimin ZHANG
1
;
Yuanfan XIAO
1
;
Jie CHEN
1
;
Qimin ZHAN
1
Author Information
1. Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Laboratory of Molecular Oncology, Peking University Cancer Hospital & Institute, Beijing 100142, China.
- Publication Type:Journal Article
- Keywords:
Cancer-associated fibroblasts;
Esophageal squamous cell carcinoma;
G-protein-coupled receptor;
IL-11;
IL-6;
JAK2;
PAFR;
Stat3
- From:
Acta Pharmaceutica Sinica B
2023;13(2):694-708
- CountryChina
- Language:English
-
Abstract:
Stroma surrounding the tumor cells plays crucial roles for tumor progression. However, little is known about the factors that maintain the symbiosis between stroma and tumor cells. In this study, we found that the transcriptional regulator-signal transducer and activator of transcription 3 (Stat3) was frequently activated in cancer-associated fibroblasts (CAFs), which was a potent facilitator of tumor malignancy, and formed forward feedback loop with platelet-activating factor receptor (PAFR) both in CAFs and tumor cells. Importantly, PAFR/Stat3 axis connected intercellular signaling crosstalk between CAFs and cancer cells and drove mutual transcriptional programming of these two types of cells. Two central Stat3-related cytokine signaling molecules-interleukin 6 (IL-6) and IL-11 played the critical role in the process of PAFR/Stat3 axis-mediated communication between tumor and CAFs. Pharmacological inhibition of PAFR and Stat3 activities effectively reduced tumor progression using CAFs/tumor co-culture xenograft model. Our study reveals that PAFR/Stat3 axis enhances the interaction between tumor and its associated stroma and suggests that targeting this axis can be an effective therapeutic strategy against tumor malignancy.
